GlassScriptPhysician profile
Shani Patel
NPI 1619465747
$3,009.25
in general payments reported to CMS, 2019-2025
18 companies · $772 in 2025
The $772 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.96 · 2021: $206 · 2022: $985 · 2023: $872 · 2024: $160 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241 · Travel and Lodging: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.28 |
| Travel and Lodging | $562.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,163.96 | 2022-2023 | Single Use Suction Valve (Sterile) |
| Astrazeneca Pharmaceuticals LP | $383.00 | 2021-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $321.36 | 2022-2025 | Nucala |
| Genzyme Corporation | $225.06 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $175.45 | 2019-2024 | Ofev |
| Insmed, INC. | $151.77 | 2022-2025 | Arikayce |
| Electromed, INC. | $143.96 | 2024-2025 | Smartvest |
| Verona Pharma, INC. | $97.53 | 2025 | Ohtuvayre |
| Philips North America LLC | $79.21 | 2025 | Vest Therapy Und |
| Grifols USA, LLC | $55.22 | 2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $34.04 | 2025 | Zerbaxa |
| Regeneron Healthcare Solutions, INC. | $33.09 | 2025 | Dupixent |
| United Therapeutics Corporation | $30.84 | 2024 | Tyvaso |
| Edwards Lifesciences Corporation | $29.65 | 2022 | |
| Pulmonx Corporation | $25.44 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $21.10 | 2024 | Hizentra |
| Shionogi INC | $20.02 | 2025 | Fetroja |
| Intuitive Surgical, INC. | $18.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shani Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.